For five years now, Dr. Mostafa Analoui has been helping US drugmaker Pfizer Inc. to identify new methods for developing pharmaceuticals. He attaches a central role to nanotechnology. At the same time, he cautions investors and patients against overblown expectations.
«Nanotechnology can save thousands of lives»
Emagazine, 23. November 2006